Free shipping on all orders over $ 500

Pyridoclax

Cat. No. M13381
Pyridoclax Structure
Size Price Availability Quantity
5mg USD 80  USD80 In stock
10mg USD 135  USD135 In stock
50mg USD 476  USD476 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pyridoclax is a potential McL-1 inhibitor.

Chemical Information
Molecular Weight 426.51
Formula C29H22N4
CAS Number 1651890-44-6
Solubility (25°C) DMSO ≥ 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] A C Groo, et al. Int J Pharm. Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer

[2] Martina De Pascale, et al. ChemMedChem. Synthesis of Pyridoclax Analogues: Insight into Their Druggability by Investigating Their Physicochemical Properties and Interactions with Membranes

[3] A Bourafai-Aziez, et al. J Biomol Struct Dyn. Binding mode of Pyridoclax to myeloid cell leukemia-1 (Mcl-1) revealed by nuclear magnetic resonance spectroscopy, docking and molecular dynamics approaches

[4] Willy Smeralda, et al. Eur J Pharm Sci. Microplate assay for lipophilicity determination using intrinsic fluorescence of drugs: Application to a promising anticancer lead, pyridoclax

[5] Siham Hedir, et al. Eur J Med Chem. Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode

Related Bcl-2 Products
BAD (103-127) (human)

BAD (103-127) (human), the 25-mer Bad peptide, is derived from the BH3 domain of BAD, can antagonize the function of Bcl-xL.

Bim BH3, Peptide IV

Bim BH3, Peptide IV is a 26-residue peptide from BH3-only protein Bim, which belongs to the pro-apoptotic group of the Bcl-2 family of proteins.

Bax inhibitor peptide, negative control

Bax inhibitor peptide, negative control is a inhibitor of Bax.

Bad BH3 (mouse)

Bad BH3 (mouse) is a biological active peptide.

Bid BH3 (80-99)

Bid BH3 (80-99) is a biological active peptide.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pyridoclax supplier, Bcl-2, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.